Trial Profile
Phase III study of RegorAfenib VErsus placebo as maintenance therapy in RAS wiLd type metastatic coLOrectal cancer
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms RAVELLO
- 29 May 2015 Trial design presented at 51st Annual Meeting of the American Society of Clinical Oncology.
- 11 Dec 2014 New trial record